$40 / mo
S3 Intermediate D26 Stakeholder Impact
Intermediate Stakeholder Impact Assessment for Clinical Research Operations: evaluate how a change affects different groups, roles, rights, burdens, and benefits.
AI Skill Collections
Obserra EPI AI Agent Capability Skills Repository — Set 3 Final Add-ons
Explore 5,000 individual capabilities included in Obserra EPI AI Agent Capability Skills Repository — Set 3 Final Add-ons.- Included offerings
- 5,000
- Experience levels
- Beginner · Intermediate · Expert
- Ways to buy
- Monthly
Individual products and skills
5,000 matching offerings
- $40 / mo
S3 Intermediate D26 Succession Plan
Intermediate Succession Planning for Clinical Research Operations: prepare ethical, evidence-based coverage and development for critical roles.
- $40 / mo
S3 Intermediate D26 Talent Map
Intermediate Talent Mapping for Clinical Research Operations: map role-relevant capability, experience, aspiration, mobility, and development across a population.
- $40 / mo
S3 Intermediate D26 Tradeoff Analysis
Intermediate Tradeoff Analysis for Clinical Research Operations: make competing benefits, costs, risks, timing, and stakeholder effects explicit.
- $40 / mo
S3 Intermediate D26 Vendor Scorecard
Intermediate Vendor Scorecard for Clinical Research Operations: measure supplier performance using governed commitments, outcomes, risks, and evidence.
- $40 / mo
S3 Intermediate D26 What If Analysis
Intermediate What-If Analysis for Clinical Research Operations: evaluate consequences of defined changes, disruptions, or policy choices.
- $40 / mo
S3 Intermediate D26 Workforce Plan
Intermediate Workforce Planning for Clinical Research Operations: align future work demand with skills, capacity, locations, sourcing, and cost.
- $40 / mo
S3 Intermediate D26 Workshop Design
Intermediate Workshop Design for Clinical Research Operations: create a participatory session that produces a tested shared output.
- $40 / mo
S3 Intermediate D27 Approval Flow
Intermediate Approval-Flow Design for Pharmaceutical Operations: route decisions to the right authority with evidence, thresholds, segregation, and timely escalation.
- $40 / mo
S3 Intermediate D27 Budget Model
Intermediate Budget Modeling for Pharmaceutical Operations: translate plans into time-phased funding, cost, cash, and variance assumptions.
- $40 / mo
S3 Intermediate D27 Business Case
Intermediate Business Case Building for Pharmaceutical Operations: justify a decision through problem evidence, options, economics, risk, and delivery feasibility.
- $40 / mo
S3 Intermediate D27 Coaching Plan
Intermediate Coaching Plan for Pharmaceutical Operations: support an individual in improving specific behavior and results through reflection, practice, and feedback.
- $40 / mo
S3 Intermediate D27 Communication Plan
S3 Intermediate D27 Communication Plan helps move Pharmaceutical Operations work from a clear request to a usable outcome.
- $40 / mo
S3 Intermediate D27 Competency Model
Intermediate Competency Modeling for Pharmaceutical Operations: define observable knowledge, skills, behaviors, and proficiency for a role or capability.
- $40 / mo
S3 Intermediate D27 Contract Review
Intermediate Contract Review Support for Pharmaceutical Operations: organize business, operational, financial, privacy, security, and delivery issues for qualified review.
- $40 / mo
S3 Intermediate D27 Control Design
Intermediate Control Design for Pharmaceutical Operations: design preventive, detective, corrective, and directive mechanisms for a defined risk.
- $40 / mo
S3 Intermediate D27 Dependency Sequence
Intermediate Dependency Sequencing for Pharmaceutical Operations: order work so prerequisites, approvals, resources, and interfaces are ready when needed.
- $40 / mo
S3 Intermediate D27 Escalation Design
Intermediate Escalation Design for Pharmaceutical Operations: define when, how, and to whom unresolved or high-consequence conditions move.
- $40 / mo
S3 Intermediate D27 Exception Design
Intermediate Exception Design for Pharmaceutical Operations: create a controlled route for justified deviation without normalizing noncompliance.
- $40 / mo
S3 Intermediate D27 Feasibility Study
Intermediate Feasibility Study for Pharmaceutical Operations: determine whether an outcome is viable across technical, operational, economic, legal, and schedule dimensions.
- $40 / mo
S3 Intermediate D27 Feedback System
Intermediate Feedback System Design for Pharmaceutical Operations: create reliable collection, interpretation, response, and closure of stakeholder feedback.
- $40 / mo
S3 Intermediate D27 Impact Analysis
Intermediate Impact Analysis for Pharmaceutical Operations: trace direct and indirect effects of a proposed or observed change.
- $40 / mo
S3 Intermediate D27 Knowledge Transfer
Intermediate Knowledge Transfer for Pharmaceutical Operations: move critical know-how between people or teams with demonstrated recipient capability.
- $40 / mo
S3 Intermediate D27 Meeting Design
Intermediate Meeting Design for Pharmaceutical Operations: structure a meeting around a necessary decision, coordination outcome, or work product.
- $40 / mo
S3 Intermediate D27 Mentoring Plan
Intermediate Mentoring Plan for Pharmaceutical Operations: structure experience-based guidance, exposure, and development for a mentee.
- $40 / mo
S3 Intermediate D27 Operating Model
Intermediate Operating Model Design for Pharmaceutical Operations: define how strategy is executed through capabilities, structure, governance, process, information, and measures.
- $40 / mo
S3 Intermediate D27 Option Generation
Intermediate Option Generation for Pharmaceutical Operations: create materially different, feasible ways to achieve an outcome.
- $40 / mo
S3 Intermediate D27 Portfolio Balance
Intermediate Portfolio Balancing for Pharmaceutical Operations: allocate attention and investment across value, risk, horizon, dependency, and capacity.
- $40 / mo
S3 Intermediate D27 Process Redesign
Intermediate Process Redesign for Pharmaceutical Operations: create a future workflow that improves outcomes while preserving necessary controls.
- $40 / mo
S3 Intermediate D27 Readiness Review
Intermediate Readiness Review for Pharmaceutical Operations: determine whether people, process, technology, data, support, and governance can proceed.